Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway. The firm's preclinical candidates include LABP-73, LABP-66, and LABP-69. The company was founded by Josep Bassaganya-Riera in January 2017 and is headquartered in Blacksburg, VA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Landos Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Landos Biopharma Inc market cap is $71.47M.
What is the 52-week high for Landos Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Landos Biopharma Inc 52 week high is $22.94 as of September 09, 2025.
What is the 52-week low for Landos Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Landos Biopharma Inc 52 week low is $21.90 as of September 09, 2025.
What is Landos Biopharma Inc stock price today?
Landos Biopharma Inc stock price today is $22.93.
What was Landos Biopharma Inc stock price yesterday?
Landos Biopharma Inc stock price yesterday was $22.80.
What is the PE ratio of Landos Biopharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Landos Biopharma Inc’s P/E ratio is -5.74.
What is the Price-to-Book ratio of Landos Biopharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Landos Biopharma Inc P/B ratio is 3.0866.
What is the 50-day moving average of Landos Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Landos Biopharma Inc 50-day moving average is $22.93.
